New medication helps heart health in people with chronic kidney disease, Type 2 diabetes

(American Heart Association) Results of a large, international clinical trial on the novel medication finerenone indicate it reduced the rate of death, heart attack, stroke and hospitalization for heart failure among patients with chronic kidney disease and Type 2 diabetes. Finerenone helped patients with chronic conditions improve their heart health, regardless of if they had a history of cardiovascular disease.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news